Delivery Order SPE2DB24D6041-SPE2DB25FKCJY
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,072.97 for DESCOVY 200-25 mg tablets (30-count units) on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $29,898.04 for DESCOVY 200-25 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed price contract, executed without set-aside provisions, represents a competitively awarded procurement under the agency's pharmaceutical supply chain. The award is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, leveraging the...
- The Defense Logistics Agency awarded a delivery order valued at $24,376.15 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $35,053.65 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets in quantities of 30, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction within the federal pharmaceutical supply chain serving military and defense healthcare operations. This award is issued as a child delivery order under...
- The Defense Logistics Agency awarded a delivery order valued at $14,991.82 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 29, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through full and open competition. This delivery order is issued...
- The Defense Logistics Agency's Medical Supply Chain awarded a $47,021.50 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of DESCOVY 200-25 mg tablets (30-unit packs). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order...
- The Defense Logistics Agency awarded a delivery order valued at $5,842.52 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets in quantities of 30 units. The contract is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of DESCOVY 200-25 MG tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $21,761.46 and is scheduled for completion by July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office...
- This delivery order, valued at $4,138.47, awards AmerisourceBergen Drug Corp the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. The contract, issued by the Defense Logistics Agency under the Department of Defense, is a non-set-aside, competitively awarded delivery order with firm fixed pricing. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. This delivery order is issued as a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $5,662.17 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's...
- SPE2DB24D6041Indefinite Delivery Contract
- SPE2DB24D6041-SPE2DB25FKCJYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,327.29 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count unit dosage) with a firm fixed price structure. The award, issued on July 31, 2025, is set to be completed by August 1, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical supply vehicle enables the contractor to deliver medications and medical supplies to support federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant position as a prime vendor within the DLA's global medical supply chain. As a critical supplier of brand-name and generic medications across multiple therapeutic domains, the company regularly fulfills federal procurement requirements through competitively awarded delivery orders under its comprehensive IDC. This specific award for DESCOVY, a prescription medication, reflects the company's ongoing role in supporting military and federal healthcare procurement needs through its extensive pharmaceutical distribution capabilities and established relationship with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/31/25 |